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Abstract. The regulatory role of parathyroid hormone 
(PTH)/PTH-related peptide (PTHrP) signaling has 
been implicated in embryonic skeletal development. 
Here, we studied chondrogenic differentiation of the 
mouse embryonal carcinoma-derived clonal cell line 
ATDC5 as a model of chondrogenesis in the early 
stages of endochondral bone development. ATDC5 
cells retain the properties of chondroprogenitor cells, 
and rapidly proliferate in the presence of 5% FBS. In- 
sulin (10 ixg/ml) induced chondrogenic differentiation 
of the cells in a postconfluent phase through a cellular 
condensation process, resulting in the formation of car- 
tilage nodules, as evidenced by expression of type II 
collagen and aggrecan genes. We found that differenti- 
ated cultures of ATDC5 cells abundantly expressed the 
high affinity receptor for PTH (M  r ~'-~80 kD; K d =  3.9 
nM; 3.2 x  105 sites/cell). The receptors on differenti- 
ated cells were functionally active, as evidenced by a 
PTH-dependent activation of adenylate cyclase. Spe- 
cific binding of PTH to cells markedly increased with 
the formation of cartilage nodules, while undifferenti- 
ated cells failed to show specific binding of PTH. 
Northern blot analysis indicated that expression of the 
PTH/PTHrP receptor gene became detectable at the 
early stage of chondrogenesis of ATDC5 cells, preced- 
ing induction of aggrecan gene expression. Expression 
of the PTH/PTHrP receptor gene was undetectable in 
undifferentiated cells. The level of PTH/PTHrP recep- 
tor mRNA was markedly elevated parallel to that of 
type II collagen mRNA. These lines of evidence sug- 
gest that the expression of functional PTH/PTHrP re- 
ceptor is associated with the onset of chondrogenesis. 
In addition, activation of the receptor by exogenous 
PTH or PTHrP significantly interfered with cellular 
condensation and the subsequent formation of cartilage 
nodules, suggesting a novel site of PTHrP action. 
I 
T has  been  suggested  that  when  limb  mesenchymal 
cells move away from the influence of the apical ecto- 
dermal ridge,  their cAMP content increases, trigger- 
ing  chondrogenic  differentiation  (38).  The  response  of 
limb mesenchymal cells to dibutyryl cAMP is a responsive 
property of the cells, which changes temporally and spa- 
tially during limb differentiation (57). Elevation of cAMP 
content of the subridge mesenchymal cells precludes the 
necessity of cells passing through a condensation phase be- 
fore overt cartilage formation (38). Thus, the increase in 
intracellular cAMP is hypothesized to be a key cellular re- 
sponse to cellular condensation that is a prerequisite for 
limb chondrogenesis (46, 49). 
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We  previously  reported  that  parathyroid  hormone 
(PTH) 1 stimulates  sulfate  incorporation  into  cartilage- 
characteristic  proteoglycans followed by elevation of in- 
tracellular  cAMP in  primary growth plate  chondrocytes 
(23, 59, 60). This stimulation of sulfate incorporation was 
mainly caused by elongation of glycosaminoglycan chains 
rather than increased synthesis of proteoglycan core pro- 
tein (23). Chondrocytes respond to PTH through the ade- 
nylate cyclase-coupled surface receptor, whose molecular 
mass was determined  to be N80 kD by chemical cross- 
linking  (22).  Cell-surface  expression  of  the  receptor  is 
1. Abbreviations used in this paper, b, bovine; BMP, bone morphogenetic 
protein; EC, embryonal carcinoma; HSAB, N-hydroxysuccinimidyl-4-azi- 
dobenzoate; MIX, 1-methyl-3-isobutylxanthine; PKA, PKC, protein ki- 
nase A, protein kinase C; PTH, parathyroid hormone; PTHrP, parathy- 
roid hormone-related peptide. 
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netic protein (BMP) in association with chondrocyte mat- 
uration (22). In a previous study, PTH stimulated prolifer- 
ation of primary growth plate chondrocytes isolated from 
rabbit  ribs  (36).  PTH  shares  a  common  receptor  with 
PTH-related peptide (PTHrP), which was originally iden- 
tified as a  causative agent of humoral hypercalcemia of 
malignancy (30,  31,  55).  Unlike PTH, the expression of 
PTHrP has been demonstrated in a  variety of fetal and 
postnatal tissues in normal animals (8, 50). The tissue dis- 
tribution of PTHrP  and its receptor suggests that PTH/ 
PTHrP may play a role as a paracrine regulator of cellular 
growth and differentiation, and that it is involved in epi- 
thelial-mesenchymal  interactions  during  early  embryo- 
genesis  (42,  62,  63).  Transgenic  mice  that  overexpress 
PTHrP provided evidence for its role in hair follicle devel- 
opment (64). 
Mice homozygous for the PTHrP null mutation exhib- 
ited widespread abnormalities of endochondral bone de- 
velopment with no effect on intramembranous bone for- 
mation (4, 32). The absence of morphological abnormalities 
in other tissues indicates the critical importance of PTH/ 
PTHrP  signaling in  embryonic chondrogenesis  and  the 
subsequent replacement of cartilage by bone. Mechanisms 
regulating chondrogenic differentiation have been  eluci- 
dated mainly by using mesenchymal cells isolated from 
chick limb buds. One of this paper's authors (T. Atsumi) 
previously  established  a  chondrogenic  clonal  cell  line, 
ATDC5, isolated from mouse embryonal carcinoma (EC) 
cells (5). Assuming a fibroblastic shape, ATDC5 cells rap- 
idly proliferate to form a confluent monolayer until growth 
ceases as a result of contact inhibition. Supplementation of 
culture medium with insulin, however, induces typical cel- 
lular condensation before overt chondrogenesis. The high 
frequency of conversion of cells to chondrocytes enabled 
us to readily monitor the differentiation stages of the cells 
in molecular and biochemical terms. Taking advantage of 
inductive chondrogenesis in vitro, we correlated establish- 
ment of the PTH/PTHrP-signaling system with the initial 
stage of endochondral bone formation. Moreover, the po- 
tential role of PTH/PTHrP actions on cellular condensa- 
tion is also discussed. 
Materials and Methods 
Cell Lines and Culture Conditions 
ATDC5 cells were cultured in the maintenance medium consisting of a 1:1 
mixture of DME  and Ham's F-12 medium (Flow Laboratories,  Irvine, 
U.K.) containing 5%  FBS  (GIBCO  BRL, Gaithersburg, MD), 10 i-~g/ml 
human transferrin (Boehringer Mannheim GmbH, Mannheim, Germany), 
and 3 ×  10  -8 M sodium selenite (Sigma Chemical Co., St. Louis, MO), as 
previously described (5). Inoculum size of the cells was 2 ×  104 cells/well 
in a 24-multiwell plate, 4 ×  104 cells/well in a 12-multiwell plate, or 6 ×  104 
cells/well in a 6-multiwell plate (Coming, Coming, NY). For induction of 
chondrogenesis, the cells were cultured in maintenance medium supple- 
mented with 10 Ixg/ml bovine insulin (Wako Pure Chemical, Osaka, Ja- 
pan); we refer to this medium as differentiation medium. Cells were main- 
tained at 37°C in a humidified atmosphere of 5% CO2 in air. The medium 
was replaced every other day. In some experiments, the cells were cultured in 
maintenance medium supplemented with 300 ng/ml human recombinant 
insulin-like growth factor-I (rhIGF-I (GIBCO BRL)) instead of insulin. 
To determine the growth curve, ATDC5 cells were inoculated in 24- 
multiwell plates and cultured in maintenance medium or differentiation 
medium containing insulin (10  ~g/ml). The cells were then rinsed with 
PBS twice, treated with trypsin, and counted with a hemocytometer. On 
day 10 of culture or later, the number of cells was corrected according to 
the DNA content of the culture, since differentiated ATDC5 cell aggre- 
gates that formed failed to dissociate by trypsinization. Determination of 
the DNA content was performed by the method of Johnson-Wint (27). 
Receptor Binding of [125I]PTH(1-34) 
ATDC5 cells were grown in 24-multiwell plates. [Nle  8, Nle TM, Tyra4]bovine 
PTH-(1-34) amide (bPTH(1-34); Bachem, Torrance, CA) was labeled by 
the chloramine-T method as previously described (55). The resultant 125I- 
labeled btrFH(1-34)  ([125I] bPTH(1-34); 2,200 Ci/mmol) was purified by 
reverse-phase HPLC on a  ixBondasphere C18 column (Waters, Milford, 
MA). To monitor the appearance of specific binding sites, ATDC5 cells 
were cultured in differentiation medium. After the indicated times in cul- 
ture, the cells were rinsed with binding buffer containing 50 mM Tris-HCl 
(pH 7.7), 100 mM NaCl, 5 mM KC1, 2 mM CaCl  2, 5%  heat-inactivated 
horse serum and then incubated at 15°C for 4 h in the same buffer contain- 
ing [125I]bPTH(1-34)  (17 pM) (54). Cells were then rinsed five times with 
ice-cold binding buffer, and the cell-associated radioactivity was counted 
after cell lysis with 0.2 M NaOH. Nonspecific binding was assessed by the 
addition of 1 I-~M bPTH(1-34). For saturation analysis, [125I]bPTH(1-34) 
with a low specific activity (220 Ci/mmol) was prepared by iodination of 
bPTH(1-34) with a mixture of NaJ27I and Na125I at a molar ratio of 9:1 (54). 
For saturation studies, cells were incubated with varying concentrations of 
[125I]bPTH(1-34) with a low specific activity for 4 h at 15°C under condi- 
tions otherwise identical to those described above. Equilibrium binding 
data from the saturation experiments were  analyzed by the method of 
Scatchard. 
Binding components for bPTH(1-34) were covalently cross-linked with 
[125I]bPTH(1-34)  photochemically as previously described  (55).  Briefly, 
ATDC5 cells cultured for 3 wk were rinsed once with binding buffer, and 
incubated in the same buffer containing 800 pM [125I]bPTH(1-34)  in the 
presence or absence of 1  I~M bPTH(1-34)  for 4  h  at  15°C.  Cells were 
rinsed three times with ice-cold PBS, reincubated at 4°C with PBS, and 
then reacted in the dark with 0.5 mM N-hydroxysuccinimidyl-4-azidoben- 
zoate (HSAB; Pierce, Rockford, IL) for 10 min followed by photolysis for 
20 min at 4°C. The cells were mixed with SDS sampling buffer and heated 
at 80°C for 20 min. Aliquots were subjected to SDS-PAGE analysis on 
5-15% linear gradient gels and subsequent autoradiography. 
Measurement of  Adenylate Cyclase  Activity in 
Response to PTH(1-34) 
Stimulation of cAMP accumulation in ATDC5 cells was assayed by  a 
modification of the method described previously (55).  Briefly, ATDC5 
cells were plated in 24-multiwell plates. Cells were rinsed once with Ham's 
F-12 medium (Nissui, Tokyo, Japan) containing 25 mM Hepes (pH 7.65, 
22°C) and 0.1%  (wt/vol)  heat-inactivated BSA, and then incubated for 
30 min at  room temperature  in the above medium containing 0.5  mM 
1-methyl-3-isobutylxanthine (MIX; Sigma) and various concentrations of 
bPTH(1-34). The reaction was terminated by addition of ice-cold HCI to a 
final concentration of 0.1 M. The samples were boiled for 3 min to extract 
cAMP and then diluted with distilled water. Total cAMP in the cell layer 
and  medium was  determined  by  radioimmunoassay as  previously de- 
scribed (55). 
RNA Extraction and Hybridization Analysis 
ATDC5 cells were inoculated in six-multiwell plates and cultured in dif- 
ferentiation medium. Total RNA was prepared from the cultures by a sin- 
gle-step method according to Chomczynski and Sacchi (11).  Total RNA 
(20 ~g) was denatured with 6% formaldehyde, separated by 1% agarose 
electrophoresis,  and  transferred  on  Nytran  membranes (Schleicher  & 
Schuell, Dassel, Germany).  Hybridization was performed overnight  at 
42°C with an appropriate probe (106 cprn/ml) in solutions containing 50% 
formamide, 6× SSPE (2× SSPE contains 0.3 M NaC1, 20 mM NaH2PO4, 
2 mM EDTA at pH7.4), 0.2% BSA, 0.2% Ficoll 400, 0.2% polyvinylpyr- 
rolidone, 0.1% SDS, and 100 ~g/ml denatured salmon sperm DNA. Hy- 
bridization probes were prepared by the random-primer method with a 
BcaBEST labeling kit (Takara, Otsu, Japan) using the appropriate cDNA 
fragments: a 1.4-kb EcoRI fragment of pKT1180 (34) as a probe for al(II) 
collagen mRNA; a 1.4-kb EcoRI fragment of p1310 (13) as a probe for ag- 
grecan mRNA; and a 2.2-kb EcoRI-XhoI fragment of pcDNAIR15B (3) 
as  a  probe  for  PTH/PTHrP  receptor  mRNA. The filters were  washed 
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X-OMAT film (Eastman Kodak Co., Rochester, NY) at  -80°C with a 
Cronex lightening plus intensifying screen (DuPont, Boston, MA). For 
slot-blot hybridization analysis, RNA (4 or t  p.g) was isolated and dena- 
tured with 6%  formaldehyde and applied to Nytran membranes with a 
Schleicher &  Schuell Manifold II slot-blot apparatus. Quantification was 
performed by scanning densitometry of the autoradiographs with a Hoe- 
fer  GS-300  scanning densitometer (Hoefer  Scientific  Instruments, San 
Francisco, CA). 
Reverse Transcription PCR 
First-strand cDNA was synthesized using SuperScript II RNase H-  re- 
verse  transcriptase  (GIBCO  BRL)  with  total  RNA  extracted  from 
ATDC5 cells according to the manufacturer's instructions. Briefly, puri- 
fied total RNA (2.5  ~g) was incubated at 42°C for 60 min with a mixture 
of 100 U  of SuperScript  II RNase H-  reverse transcriptase; 2.5  txM of 
oligo-d(T)16 primer  (Perkin  Elmer  Cetus Corp.,  Norwalk,  CT);  3  mM 
MgC12; 50  mM Tris-HCl (pH  8.3);  75 mM KC1;  1 mM each of dCTP, 
dTTP, dGTP, and dATP; 5 mM DTT in a volume of 10 p.1. Aliquots of one 
tenth of the cDNA were used to amplify types I and II collagen genes by 
PCR (1). A primer set specific for the mouse glyceraldehyde 3-phosphate 
dehydrogenase (G3PDH) gene (Clontech, Palo Alto, CA) was used as a 
positive control for amplification of cDNA. The expected size of the am- 
plified DNA fragment was 983 bp. The PCR conditions were 94°C for 30 s, 
60°C for 1 min, 72°C for 1 rain for 20 cycles, and final extension at 72°C for 
5 rain. Primers specific for the pro-c~2(I)  collagen gene were 5'-GAACG- 
GTCCACGAqTGCATG-3'  (forward  direction)  and  5'-GGCATGT- 
TGCTAGGCACGAAG-3' (reverse direction)  (1). Primers for the pro- 
al(lI) collagen gene were 5'-CACACTGGTAAGTGGGGCAAGACCG- 
3' (forward direction) and 5'-GGATTGTGTTGTTTCAGGGTTCGGG- 
3' (reverse direction) (1). The distances between the forward and reverse 
primers for pro-a2(I) and pro-al(II) collagen genes were 167 and 172 bp, 
respectively. Aliquots (5 ~1) of the PCR reaction were resolved on 4% 
NuSieve 3:1 agarose gels (FMC BioProducts, Rockland, ME) along with 
molecular size markers, and the amplified products were stained with ethid- 
ium bromide. The amplified PCR products were subcloned into pCRII 
(Invitrogen, San Diego, CA), and their sequences were confirmed with a 
Prism 310 genetic analyzer (Applied Biosystems, Inc., Foster City, CA). 
Alcian Blue Staining 
ATDC5 cells were plated in 12-multiwell plates and cultured in differenti- 
ation medium. At each time point, cells were rinsed with PBS and fixed 
with 95% methanol for 20 rain. They were then stained with 0.1% Alcian 
blue 8GS (Fluka, Buchs, Switzerland) in 0.1 M HCl overnight. 
Treatment of Cells with PTH Analogues and PTHrP 
To assess the effects of PTH and PTHrP on chondrogenesis, ATDC5 ceils 
were plated in 12-multiwell plates. When the cells reached confluency in 
differentiation medium on day 3, cultures were treated with the following 
test samples: bPTH(1-34), [Tyr34]bovine  PTH-(7-34) amide (bPTH(7-34); 
Peptide Institute, Osaka, Japan) and human PTHrP(1-141) (hFFHrP(1-141); 
a  generous gift from Dr. T.J.  Martin [St.  Vincent's Institute of Medical 
Research, Fitzroy, Victoria, Australia]). The cells were treated with these 
agents for another 12 d, with replacement of the medium every other day. 
Effects on cellular condensation and differentiation were monitored by 
phase-contrast microscopy and Alcian blue staining of the cells. Secretion 
of endogenous PTHrP  by  the  cells was  examined by determining the 
PTHrP level in the medium conditioned for 3 d using an Allegro PTHrP 
immunoassay  kit (Nicholas Institute, San Juan Capistrano, CA). 
Results 
Cell Growth and Chondrogenesis of  ATDC5 Cells 
A  clonal chondrogenic cell line, ATDC5, was established 
from a  differentiated  culture  of EC-derived AT805  cells 
on the basis of its chondrogenic potential (5). As shown in 
Fig.  1,  ATDC5  cells  were  inoculated  into  24-multiwell 
plates and maintained in DME/F-12 supplemented with 10 
Ixg/ml human transferrin, 3 ×  10 -s M sodium selenite, and 
107. 
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Growth curves of ATDC5 cells. Cells were cultured  in 
24-multiwell plates in maintenance medium in the absence of in- 
sulin ([]) or in the presence of 10 txg/ml insulin (¢,). Total cell 
numbers in culture were determined for three wells at each time 
point,  as  described  in  Materials  and Methods.  Values are the 
means of three wells. SEM were so small that they are hidden by 
the symbols. The figure represents one of two independent ex- 
periments with similar results. 
5% FBS (the maintenance medium). ATDC5 cells rapidly 
proliferated with  a  short doubling time of 16  h  (Fig.  1). 
The cells exhibited an elongated fibroblastic morphology 
at the subconfluent stage (Fig. 2 a). On day 3 of culture, 
the cells stopped growing at confluence to form a mono- 
layer in which they remained undifferentiated with a fibro- 
blastic morphology (Fig. 2 b). Under these conditions, sat- 
uration cell density was ~2.5  ×  105 cells/well (1.41  ×  105 
cells/cm2). No Alcian blue-positive cartilage nodules  ap- 
peared in these cultures. 
Alternatively,  the  cells  were  grown  in  differentiation 
medium containing 10 ~g/ml insulin. Insulin did not signif- 
icantly affect cell doubling time (Fig. 1) or the morphology 
of the cells in the growth phase. Upon attainment of con- 
fluency, the cells similarly ceased to grow by contact inhi- 
bition.  Within  the  three  days after confluency, however, 
the culture reentered  the growth state with a  longer cell 
doubling time to form numerous nodular structures by day 
21  (Fig.  2  c).  A  transient  condensation  of cells  with  an 
elongated spindle-like morphology (Fig. 2 d) preceded for- 
mation of the nodules, as seen in mesenchymal condensa- 
tion in limb bud chondrogenesis  (14). The nodular struc- 
tures formed were composed of proliferating cells with a 
round morphology (Fig. 2 e). Logarithmic growth of cells 
in the postconfluent phase occurred for ~4 d, from days 
6-10 (Fig. 1). The doubling time of the cells during this pe- 
riod was ~48 h, consistent with what was reported previ- 
ously (5). IGF-I (300 ng/ml) also induced cellular conden- 
sation and the subsequent formation of cartilage nodules 
(Fig. 2 f). However, IGF-I was not as effective as insulin 
for chondrogenic induction of the cells. As shown in Fig. 3, 
Alcian  blue-positive cartilage  nodules  were  first detect- 
able between  days 6  and  10,  and  they increased  in size. 
Then the apparent growth rate of the culture decreased, 
probably because a portion of the differentiated ceils be- 
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crographs  of  ATDC5  cells. 
Cells were cultured  in main- 
tenance medium in a  and b 
or in differentiation  medium 
in  (c-f)  in  24-multiwell 
plates.  (a)  Cells  at  the  sub- 
confluent  stage  on day 2  of 
culture.  (b)  Cells  at  conflu- 
ency on day 3 are shown at a 
higher  magnification.  (c) 
Typical  cartilage  nodules 
were formed by day 21. Cells 
at the condensation  stage on 
day 6 and at the growth stage 
of cartilage  nodules  on  day 
14 are shown in d and e, re- 
spectively. (f) The cells were 
cultured  for  14  days  in  the 
presence  of IGF-I (300 ng/ 
ml)  instead  of insulin.  Bar, 
500 Ixm for a and c, and 100 
~m for b and d-f. 
gan to mature (Fig. 1). This postconfluent growth of cells, 
however, continued for 2 wk until day 21, and then ceased. 
On day 21, the total number of cells reached a maximum 
at 1.6 x  106 cells/well (9.1  x  105 cells/cm2). Cells surround- 
ing cartilage nodules retained their fibroblastic morphol- 
ogy and presumably did not grow during expansion of the 
nodules. Assuming that these cells were quiescent, 85% of 
the total cell population at the end of the growth stage of 
cartilage nodules was estimated to be differentiated chon- 
drocytes.  Even  after  cessation  of  postconfluent  growth, 
the Alcian blue-positive area appeared to expand by accu- 
mulation of cartilage matrix resulting from the maturation 
of cells (Fig. 3). 
Chondrogenic  differentiation  of ATDC5 cells was fur- 
ther characterized by expression of cartilage-characteristic 
extracellular matrix genes such as aggrecan (Fig. 4 a) and 
type II collagen (Fig. 4 b). Transcripts for these genes were 
undetectable  in  undifferentiated  ATDC5  cells  on  day 2 
(Fig. 4, a and b, lane 1). In contrast, these cartilage-charac- 
teristic transcripts became readily detectable in the differ- 
entiated cultures by day 14 (Fig. 4, a  and b, lane 2). Ex- 
pression of type I and type II collagen genes were compared 
by reverse transcription PCR under identical amplification 
conditions, using the specific primer sets described in Ma- 
terials and Methods (Fig. 5) (1). A  primer set specific for 
the mouse G3PDH gene was used as a positive control for 
amplification  of cDNA.  The  amplified  DNA  fragments 
were  verified  by  determination  of  their  sequence.  As 
shown in Fig. 5 a, undifferentiated ATDC5 cells on day 2 
evidently  expressed  the  type  I  collagen  gene  transcript, 
which  remained  detectable  throughout  the  experimental 
period.  In  contrast,  the  type  II collagen  gene  transcript 
was undetectable on day 2 (Fig. 5 b). It became barely de- 
tectable on day 10 and readily detectable on day 21, when 
cartilage nodules that had formed in culture ceased to grow. 
Analysis of cartilage nodules by transmission electron mi- 
croscopy indicated  that differentiated ATDC5 cells were 
surrounded by thin type II collagen fibrils (,-.~20 nm in di- 
ameter)  (20),  but  no  thick fibrils characteristic of type  I 
collagen were found (data not shown). 
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mRNAs in ATDC5 cells. Cells were grown in the differentiation 
medium in six-multiwell plates. Total RNA was isolated on day 2 
(lane  1) and on day 14 (lane  2)  of culture.  RNA (20 Ixg) was 
loaded in each lane and then hybridized with rat aggrecan cDNA 
(a) or rat type II collagen cDNA (b). The membranes were ex- 
posed to film for 24 h in a and for 6 h in b. The positions  of 28S 
and 18S ribosomal RNAs are indicated.  The lower panels  show 
ethidium bromide-stained gels. 
Figure 3.  Formation of cartilage nodules in the presence of insu- 
lin. ATDC5 cells were cultured in differentiation  medium in 12- 
multiwell plates. Cultures were stained with 0.1% Alcian blue. 
Acquisition of PTHIPTHrP Responsiveness  during 
Chondrogenic  Differentiation of  A TDC5 Cells 
It has been established that rabbit growth plate chondro- 
cytes express  PTH/PTHrP  receptors  on  their  surface  in 
vitro  (15,  22).  ATDC5  cells were  plated  in  24-multiwell 
plates, and they were maintained for 21 d in differentiation 
medium containing insulin (10 ~g/ml) until the growth of 
cartilage nodules ceased. A  saturation binding experiment 
was then carried out. Cells were incubated with incremen- 
tal doses of [125I] bPTH(1-34) in the presence or absence 
of unlabeled bPTH(1-34). Available binding sites for the 
ligand were saturable, as shown in Fig. 6 a. Scatchard anal- 
ysis indicated the presence of a single class of binding sites 
that exhibited an apparent dissociation constant of 3.9 nM 
and a binding capacity (Bmax) of 3.2 X 105 sites/cell (Fig. 6 
a; inset). Under the present experimental conditions, ~15 % 
of the cells in culture remained undifferentiated  (Fig. 1). 
Assuming that undifferentiated cells do not express PTH/ 
PTHrP receptors, the determined Bma  x value may be un- 
derestimated to some extent. Then we attempted to visual- 
ize the binding component on the differentiated cell cul- 
ture by photochemical cross-linking. Cells were incubated 
with  [125I]bPTH(1-34),  extensively  rinsed,  photoreacted 
with HSAB, and then analyzed by autoradiography after 
SDS-PAGE (Fig. 6 b). The predominant binding compo- 
nent was identified  as a  diffuse 80-kD band.  Labeling of 
the  80-kD  band  was  completely abolished  by unlabeled 
bPTH(1-34). 
Taking  advantage  of  the  inductive  chondrogenesis  of 
ATDC5 cells, we examined the differentiation-dependent 
expression  of  PTH/PTHrP  receptors  by  monitoring  the 
specific binding  of  [125I]bPTH(1-34)  (Fig.  7).  Cells  were 
maintained in differentiation medium containing 10 ixg/ml 
insulin,  and were incubated with  p25I]bPTH(1-34) in  the 
absence or presence of unlabeled bPTH(1-34). No specific 
binding was detectable on day 4, at which time no cartilage 
nodules were observed. Only 2 d  later, however, the spe- 
cific binding of [125I]bPTH(1-34) was clearly detectable; it 
amounted to 3%  on day 6,  when cartilage nodules  were 
first seen. In association with the formation and growth of 
cartilage nodules, the specific binding increased markedly 
and reached a maximum of 11% of the added radiolabeled 
ligand  on  day 21.  Nonspecific binding  remained  reason- 
ably low (from 1.0 to 1.5%) during the entire experimental 
period.  These results suggest that the  expression of cell- 
surface receptors for PTH is closely associated with chon- 
drogenic differentiation of the cells. 
The PTH/PTHrP receptor acts through activation of the 
coupled  adenylate  cyclase  (30).  The  functionality of the 
PTH/PTHrP receptor on differentiated ATDC5 cells was 
monitored  by the  ligand-dependent  activation of adeny- 
late cyclase on the basis of a  unit  number of cells in the 
culture. As shown in Fig. 8, differentiated cells exhibited a 
bPTH(1-34)-dependent  activation  of  adenylate  cyclase. 
The enzyme activity was detectable in response to ~<10 pM 
bPTH(1-34). The half effective dose EDs0 of bPTH(1-34) 
was ~0.2 nM.  Cells at the initial stage of chondrogenesis 
revealed only marginal activation of the enzyme on day 4. 
These lines of evidence suggest that acquisition  of PTH/ 
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collagen mRNA in ATDC5 cells 
by reverse transcription PCR, in 
comparison to type II collagen 
mRNA. Cells were grown in dif- 
ferentiation medium in six-mul- 
tiwell  plates.  Total  RNA  was 
isolated on day 2 (lane 1), day 10 
(lane  2),  and  day  21  (lane  3) 
from the cells grown in differen- 
tiation  medium.  Reverse-tran- 
scribed eDNA was amplified by 
PCR. Aliquots (5 Ixl) of the PCR 
products  were  resolved  on 4% 
agarose  gels  alongside  markers 
(M). The primer pairs used were 
specific  for the following target 
sequences: type I collagen in a; 
type II collagen in b; G3PDH in c. 
PTHrP responsiveness is closely associated with the onset 
of chondrogenesis. 
Induction of the PTHIPTHrP Receptor Gene during 
Chondrogenesis of  ATDC5 Cells 
We  studied  the  expression  of a  PTH/PTHrP  mRNA  in 
ATDC5 cells by Northern blotting. The rat PTH/PTHrP re- 
ceptor eDNA probe was hybridized to total RNA (20 Ixg) 
from cells at different stages of differentiation (Fig. 9 a). As 
shown in lane  1, there was no detectable  hybridization to 
RNA extracted from undifferentiated cultures of ATDC5 
cells on day 2. In contrast, on day 7, when the formation of 
cartilage  nodules was observed  in culture,  the 2.3-2.5-kb 
PTH/PTHrP  receptor  transcript  was  clearly  detectable 
(Fig. 9 a; lane 2). The mRNA level increased markedly in 
parallel  with  the  growth  of  cartilage  nodules,  and  it 
reached a maximum by day 21, when cellular proliferation 
ceased (Fig. 9 a; lanes 3 and 4); then the mRNA level grad- 
ually decreased (Fig. 9 a; lanes 5 and 6). 
The time course of changes in the PTH/PTHrP receptor 
mRNA level was determined in detail by slot blot analysis, 
a 
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Figure 6.  Cell-surface binding of [125I]bPTH(1-34) to differentiated ATDC5 cells cultured in the presence of insulin. Cells were grown in 
differentiation medium for 21 d in 24-multiwell  plates.  (a) Equilibrium saturation binding of [1zSI]bPTH(1-34) was determined in tripli- 
cate. Experiments were conducted twice with similar results.  The inset shows Scatchard analysis of the same data. (b) PTH/PTHrP re- 
ceptors on differentiated ATDC5 cells were visualized  by photochemical cross-linking  of [125I]bPTH(1-34). Cells were incubated in the 
binding buffer containing [125I]bPTH(1-34) in the absence (-) or presence (+) of unlabeled bPTH(1-34). Cells were then reacted with 
HSAB followed by photolysis. Experiments were carried out in duplicate. 
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Figure 7.  Time course of changes in binding capacity of ATDC5 
cells  to  [125I]bPTH(1-34) during  chondrogenic  differentiation. 
Cells were grown in differentiation medium in 24-multiwell plates 
for the indicated  periods.  Cells were incubated with [125I]bPTH 
(1-34) (17 pM) in the absence ([~) or presence (¢I,) of the corre- 
sponding  unlabeled ligand  (1  I~M). The cell-associated  radioac- 
tivity was counted.  Each value represents the mean -  SEM in 
triplicate  assays. The figure represents one of two independent 
experiments with similar results. 
and was compared to that of type II collagen mRNA (Fig. 
9 b). Expression of the genes was induced in parallel with 
the formation of cartilage nodules in culture. Densitomet- 
ric analysis clearly indicated that inductive expression of 
the PTH/PTHrP receptor gene coincided with expression 
of the type II collagen gene in a logarithmic manner (Fig. 9 
c). These results suggest that the expression of the PTH/ 
PTHrP receptor gene in ATDC5 cells is closely associated 
with chondrogenic differentiation. 
Effect of PTH or PTHrP on Chondrogenic 
Differentiation of  ATDC5 Cells 
To elucidate the functional role of PTH/PTHrP signaling in 
chondrogenesis, we studied the effects of PTH analogues 
on chondrogenic differentiation of ATDC5 cells (Fig. 10). 
Cells were grown to confluency in differentiation medium 
for the initial 3 d. The cells were then incubated for an addi- 
tional  12 d  with  10 -8 M  bPTH(1-34)  or hPTHrP(1-141), 
which activated adenylate cyclase to a maximal level• Both 
peptides  completely inhibited  cellular  condensation  and 
the subsequent formation of cartilage nodules  in culture 
(Fig. 10, b and c). No Alcian blue-positive cartilage matrix 
accumulated in these cells in culture (data not shown). In 
contrast, treatment with bPTH(7-34) did not affect differ- 
entiation (Fig. 10 d). 
Secretion of PTHrP, an endogenous ligand for the PTH/ 
PTHrP receptor, from ATDC5 cells was examined. Undif- 
ferentiated  ceils  were  plated  in  24-multiwell  plates  and 
grown in differentiation medium. Culture medium was re- 
placed into fresh medium and conditioned for 3 d.  Con- 
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Figure 8.  PTH-dependent adenylate cyclase activity in undiffer- 
entiated and differentiated ATDC5 cells. Cells were grown in a 
24-multiwell plate for 4 d (0) or for 21 d ([]) in the differentia- 
tion medium. Cells were incubated for 30 min with 0.5 mM MIX 
and various  doses of bPTH(1-34).  The reaction was terminated 
by addition of ice-cold HCI. Production of cAMP was assessed by 
radioimmunoassay.  Each value represents the mean __- SEM in 
triplicate  assays. The figure represents one of two independent 
experiments with the similar results. 
determined  by radioimmunoassay.  As shown in Table I, 
medium conditioned from days 2-5 contained a detectable 
level of PTHrP (4.4 pM). Concentration of PTHrP in the 
conditioned medium decreased as cell differentiation pro- 
gressed, and it was below the detection limit (<0.1 pM) on 
day  52.  Thus~  ATDC5  cells,  probably  undifferentiated 
ceils, secrete PTHrP into culture medium, but its concen- 
tration seemed too low to activate PTH/PTHrP receptor- 
coupled adenylate cyclase in the differentiated cells. 
Discussion 
Wherever bone is formed by replacement of a  cartilagi- 
nous  bone  rudiment  (endochondral  pathway),  this  rudi- 
ment is preceded in development by the appearance of a 
cellular  condensation  within  the  mesenchyme or, in  the 
case of the head, within the ectomesenchyme derived from 
the neural crest. Skeletal elements begin to become faintly 
discernible  as the  particular  regions where  cells become 
more densely packed (14). Once cells are in this condensa- 
tion state, they begin to produce large amounts of carti- 
lage-specific molecules such as type II collagen and aggrecan. 
Cultured  limb mesenchymal cells  exhibit  commitment 
and gene expression profiles in culture that closely resem- 
ble in vivo events (56). Their usefulness has been limited, 
however, by requirements for a high seeding density (39), 
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PTH/PTHrP receptor mRNA level 
during  chondrogenic  differentia- 
tion,  compared to that for type II 
collagen.  Cells  were grown  in  dif- 
ferentiation  medium  in  six-multi- 
well plates. (a) Northern blot analy- 
sis of PTH/PTHrP receptor mRNA 
is shown. Total RNA was isolated 
on day 2 (lane 1), day 7 (lane 2), day 
14 (lane 3), day 21 (lane  4), day 24 
(lane 5), and day 28 (lane 6). 20 txg 
of total  RNA  was  used  per  lane, 
and the membrane was exposed to 
film for 37 h. The positions  of 28S 
and 18S ribosomal RNAs are indi- 
cated. The lower panel shows ethid- 
ium bromide staining of the gel. (b) 
RNA isolated  on the indicated  day 
of culture was analyzed by slot blot- 
ting. 4 Ixg of total RNA was hybrid- 
ized with rat PTH/PTHrP receptor 
cDNA  probe,  and  the  membrane 
was exposed to film for 8 d (lane 1). 
1 I-tg of total RNA was hybridized 
with  rat  type  II  collagen  cDNA 
probe,  and  the  membrane was ex- 
posed to film for 17 h (lane  2).  (c) 
The  time  courses  of  changes  in 
PTH/PTHrP receptor mRNA levels ([~) and type II collagen (11),  are compared. Each mRNA level was quantified by scanning densi- 
tometric analysis of the slot blot in b. Values are expressed as percentages of the highest hybridization  intensity for each mRNA. Two 
independent experiments were performed and gave similar results. 
e.g.,  107  cells/ml,  and  the  availability of a  homogeneous 
cell population. In a high density culture of chick stage 24 
limb  mesenchymal  cells,  chondrogenesis  predominates 
with 60-85 % of cells identifiable as chondrocytes, whereas 
muscle  differentiation  is  maximal and  chondrogenesis  is 
totally lacking in low density culture (56). Thus, the molec- 
ular  analysis of chondrogenesis  awaits the  establishment 
of a  clonal cell line  capable of chondrogenic differentia- 
tion in vitro. Cell lines such as RCJ3.1  and CFK2 exem- 
plify the usefulness of a  chondrogenic clonal cell line for 
the study of skeletal development (7, 21). These cell lines, 
however, were isolated from fetal calvariae, which do not 
develop  via  the  endochondral  pathway  but  via  the  in- 
tramembranous pathway of bone formation. EC ceils are 
the stem cells of teratocarcinomas, and they show marked 
similarities to cells of the  early embryo. They lose  their 
malignancy  as  they  differentiate.  Teratocarcinoma  cells 
are therefore a useful alternative to embryos for studying 
the  processes  of  early  mammalian  development.  Since 
there may be the potential limitations of EC cells, careful 
characterization of their phenotype is required. 
ATDC5 is a  clonal cell line derived from the multipo- 
tent EC AT805, which grows in vitro without feeder cells 
(5). In the presence of insulin, ATDC5 cells differentiated 
into chondrocytes to form cartilage nodules at a very high 
frequency (Fig. 2 c), comparable to a high density micro- 
mass culture of chick limb bud cells (56). Taking on a fi- 
broblastic morphology, ATDC5 cells expressed the type I 
collagen gene transcript (Fig. 5), and they initially prolifer- 
ated with a  short doubling time (16 h) irrespective of the 
presence  of insulin.  They exhibited  contact  inhibition  at 
confluence (Fig. 1). There was neither an accumulation of 
cartilage  matrix  (Fig.  3)  nor  expression  of cartilage-spe- 
cific transcripts (Fig. 4) at this stage. In the presence of in- 
sulin,  there  transiently  appeared  condensation  areas  in 
culture  (Fig. 2  d), from which proliferating chondrocytes 
were generated to form cartilage nodules  (Fig. 2 e). The 
second phase of growth was characterized by a longer cell- 
doubling time (48 h). The progressive expression of type II 
collagen  mRNA  was  initiated  along  with  condensation 
and the subsequent growth of nodules (Figs. 3 and 9). 
In cultures of prechondrogenic mesenchymal cells from 
chick limb buds, there is a first phase in which all cells be- 
have  as  fibroblasts,  exhibiting  contact  inhibition  (14). 
These cells rapidly proliferate at this stage and there is a 
considerable  increase in  cell-doubling  time during  chon- 
drogenesis  (19).  Prechondrogenic  mesenchymal cells ex- 
press  type  I  collagen  mRNA,  but  no  type  II  collagen 
mRNA is expressed. As the cells differentiate into chon- 
drocytes through  cellular condensation,  they initiate  the 
synthesis of type II collagen. Differentiated chondrocytes 
cease synthesizing type I collagen, while they still contain 
type I collagen transcripts (37). A  marked increase in type 
II collagen mRNA level occurs coincidently with the con- 
densation stage in chondrogenesis. Thereafter, a continu- 
ous and progressive increase in the accumulation of type II 
collagen mRNA occurs (37).  With respect to their chon- 
drogenic potential, morphological appearance, growth be- 
havior, and collagen gene expression, ATDC5 cells appear 
to  retain  the  characteristics  of  chondrogenic  precursor 
cells. 
Cellular  condensation  is  an  important prerequisite  for 
The Journal of Cell Biology, Volume 133, 1996  464 Figure 10.  Effects of PTH and PTHrP on chondrogenic  differentiation.  ATDC5 cells were grown to confluency in differentiation  me- 
dium for the initial 3 d in 12-multiwell plates. The cells were then incubated for a further 12 d with no addition (a) or with 10  -8 M 
bPTH(1-34)  (b), 10  -s M hPTHrP(1-141)  (c) or 10 -s M bPTH(7-34)  (d). Formation of cartilage  nodules was examined under a phase- 
contrast microscope (xl00). Bar, 200 Fm. 
initiation  of chondrogenesis  in mesenchymal cell culture. 
In the presence of insulin, the cell density of ATDC5 cul- 
ture increased only by ~<50% during the postconfluent 3 d. 
This observation was compatible with an increase in pack- 
ing cell density during chick limb bud condensation in vivo 
(14).  At this  stage, cells lose contact inhibition of move- 
ment and grow beyond confluence to produce two or three 
layers of cells.  Recent  reports  have suggested  that  FGF 
signaling  plays  a  role  in  support  of the  proliferation  of 
limb bud mesenchyme and limb pattern formation (12, 44, 
48, 53). There is no evidence of mitotic activity required 
for onset of condensation in chick limb chondrogenesis in 
vitro.  Cellular  condensation  is  chiefly  mediated  by  a 
change of cell motility and cell--cell interactions  (40, 45). 
In  fact,  FGF-2  markedly stimulated  the  proliferation  of 
confluent ATDC5 cells, but failed to initiate condensation 
(data  not  shown).  Thus,  the  mitogenic  action  of insulin 
does not seem to be of primary importance for induction of 
condensation.  Insulin  probably  affects  cell  morphology 
and motility during differentiation of ATDC5 cells. 
IGF-I has  been  implicated  in  early limb development 
and  chondrogenesis  (18).  We  demonstrated  that  IGF-I 
also induces cellular condensation and formation of carti- 
lage nodules in cultures of ATDC5 cells. Thus, it is possi- 
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during the Course of  Differentiation In Vitro: Concentration in 
the Conditioned Medium 
Samples  Concentration of PTHrP 
Fresh differentiation medium alone 
Conditioned medium (days 2-5) 
Conditioned medium (days 7-10) 
Conditioned medium (days 20-23) 
Conditioned medium (days 35-38) 
Conditioned medium (days 52-55) 
pmoLaiter 
<0A 
4.43 +  0.88 
3.13 +  0.32 
2.38 -+ 0.03 
0.58 +-- 0.22 
<0.1 
ATDC5 cells were cultured in differentiation medium in 12-multiwen plates,  as de- 
scribed in Materials and Methods. Culture medium was replaced with fresh differenti- 
ation medium on the days indicated, which was then conditioned for 3 d. Concentra- 
tion of PTHrP  secreted was determined by radioimmunoassay. Values are means - 
SEM in triplicate assays. Experiments were conducted twice with similar  results. 
ble that insulin acts through an IGF-I signaling pathway. 
IGF-I, however, was less effective than insulin for chon- 
drogenic induction of the cells. Bassas and his co-workers 
reported the presence of insulin immunoactivity and bio- 
activity in early chick embryos (6). They also found insulin 
receptors as well as IGF-I receptors on plasma membranes 
isolated from limb buds (6).  Telford and her co-workers 
demonstrated the presence of transcripts for insulin recep- 
tors and IGF-I receptors in early mouse embryos by re- 
verse transcription PCR, and suggested a possibility that 
these embryos respond to exogenous (e.g., maternal) sources 
of insulin (61). Our preliminary experiments indicated that 
undifferentiated ATDC5 cells express transcripts for insu- 
lin receptors and IGF-I receptors (data not shown). There- 
fore, it is also possible that insulin induces differentiation 
of ATDC5 cells through an insulin-specific signaling path- 
way, although the physiological relevance of the action of 
insulin for chondrogenic induction remains to be elucidated. 
There is growing evidence to suggest that BMPs stimu- 
late differentiation of cells of the chondroblastic lineage as 
well as those of the osteoblastic lineage (10, 33, 47). Tran- 
scripts for BMP genes have been localized in mesenchy- 
mal condensations and the perichondrium in mouse em- 
bryos (28, 43). Recent studies on brachypodism and short 
ear mice implied that BMPs mediate cell-cell interactions 
during condensation and subsequent chondrogenesis (35, 
58).  Intriguingly, precondensing ATDC5 cells responded 
to exogenous BMP-2 to undergo chondrogenic differentia- 
tion without condensation (Shukunami, C., unpublished 
data). Thus, BMP-dependent serine/threonine kinase sig- 
naling may participate in the chondrogenesis of condens- 
ing ATDC5 cells, cAMP signaling, however, has also been 
implicated in limb chondrogenesis (49,  57).  Its effect on 
cartilage  differentiation in  vitro  was  dependent  on  cell 
density (46).  It is known that PTH stimulates phenotypic 
expression of differentiated chondrocytes via intracellular 
production  of  cAMP  (23,  60).  We  previously  demon- 
strated that cultured growth plate chondrocytes expressed 
80-kD PTH/PTHrP receptors on the cell surface (22).  It 
seems  unlikely, however,  that  PTH,  an  endocrine  hor- 
mone, acts as a  natural ligand for the receptor  in early 
chondrogenic development. Therefore, the physiological 
significance of PTH responsiveness was puzzling until the 
wide distribution and the early onset of PTHrP synthesis 
in embryos were observed (8, 62). 
Differentiated ATDC5 cells expressed a large number 
of 80-kD PTH/PTHrP receptors on the cell surface, and 
these  receptors  were  functionally active  in  stimulating 
adenylate cyclase (Figs. 6 and 8). The binding kinetics of 
[125I]bPTH(1-34)  were compatible with previous findings 
in primary chondrocytes (Fig. 6). Only 10 pM bPTH(1-34) 
evidently stimulated production of cAMP. The expression 
of the PTI-UPTHrP receptor transcript was readily detect- 
able in differentiated ATDC5 cells by Northern blot anal- 
ysis using total RNA (Fig. 9). On the other hand, precon- 
densing undifferentiated ATDC5 cells exhibited no specific 
binding of PTH (Fig. 7). Elevation of binding capacity was 
correlated with progression of chondrogenic differentia- 
tion of cells. Capehart (9) and Zull (65) described in their 
earlier reports that the appearance of PTH-sensitive ade- 
nylate cyclase was one of the earliest events in chick limb 
differentiation. It was unclear at the time, however, whether 
acquisition of PTH responsiveness occurred in cells of the 
chondrogenic or osteoblastic lineage. In the present study, 
we used a  clonal cell line to demonstrate unequivocally 
that acquisition of PTH responsiveness is associated with 
chondrogenic  differentiation.  The  expression  of  PTH/ 
PTHrP receptor mRNA occurred in parallel with the in- 
duction of type II collagen mRNA, and it is one of the ear- 
liest events in chondrogenic differentiation (Fig. 9). 
Segre and his co-workers suggested by in situ hybridiza- 
tion that expression of PTI-UPTHrP  receptor  mRNA is 
high in maturing chondrocytes, and that PTHrP and PTH/ 
PTHrP  receptor genes  are  expressed  in largely discrete 
but mostly neighboring areas in the developing bones in 
fetal  rats  (42).  As  shown  in  Table  I,  undifferentiated 
ATDC5 cells secreted PTHrP immunoreactivity into cul- 
ture medium. PTHrP in the medium conditioned for 3 d 
reached a  concentration of 4.4 pM. Although PTHrP in 
the conditioned medium was higher than that of normal 
human plasma, capacity of the cells for PTHrP production 
was lower than that of mammary epithelial cells that were 
isolated from lactating glands in vitro (16).  Secretion of 
PTHrP decreased as differentiation of ATDC5 cells pro- 
gressed. Since ATDC5 cells were maintained by replacing 
the medium every other day during the present study, the 
concentration  of endogenous  PTHrP  cannot  be  higher 
than  several  picomolar.  When  the  dose-response  data 
(Fig. 8) are taken into consideration, it is unlikely that en- 
dogenous PTHrP activates PTH/PTHrP receptors that are 
expressed on the surface of ATDC5 cells in culture. 
In contrast, when PTH/PTHrP receptors were continu- 
ously activated by bPTH(1-34)  or hPTHrP(1-141)  during 
differentiation of the cells, these agents inhibited the for- 
mation of cartilage nodules. There was no inhibitory effect 
by the treatment with bPTH(7-34). Upon interaction with 
the ligands, FFH/FFHrP receptors activate both the cAMP/ 
protein kinase A  (PKA) and the phospholipase C/protein 
kinase C (PKC) signal pathways (2, 25). Janulis (26) sug- 
gested that the phospholipase  C/PKC pathway mediates 
PTH stimulation of renal proximal tubule 1,25-dihydroxy- 
vitamin D 3 secretion. Because NH2-terminal amino acids 
of PTH fragments are required for adenylate cyclase acti- 
vation (17),  bPTH(7-34)  binds to PTH/PTHrP receptors 
without activation of adenylate cyclase (24). Jouishomme 
(29) reported that the PKC activation domain lies within 
the 28-34 region of the PTH molecule. Fujimori and co- 
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with  a  relative  potency  of 51%  of that  of bFlq-I(1-34). 
These  results  suggest  that  activation  of PTH/PTHrP  re- 
ceptors interferes with the early stages of chondrogenesis 
through  the  cAMP/PKA  signaling  pathway.  Recently, 
J0ppner  and his co-workers identified a single heterozy- 
gous  nucleotide  exchange  in  the  PTH/PTHrP  receptor 
gene of a patient with Jansen-type metaphyseal chondrodys- 
plasia (51, 52). The nucleotide exchange causes a missense 
mutation  in the PTH/PTHrP receptor. When the mutant 
receptor was expressed in COS-7 cells, ligand-independent 
constitutive cAMP accumulation was observed in the cells. 
Thus, it is possible that the interference of chondrogenesis 
by  constitutive  activation  of  the  PTH/PTHrP  receptors 
may account for the abnormal formation of endochondral 
bone in this rare form of short-limbed dwarfism. 
Homozygous  mice  carrying  the  PTHrP  null  mutation 
exhibited widespread abnormalities of endochondral bone 
development. Despite the wide distribution of PTHrP and 
its receptor transcripts in the body, there were no morpho- 
logical abnormalities in other tissues (4, 32). Animals ho- 
mozygous for the null mutant of the PTH/PTHrP receptor 
displayed  essentially  the  same  abnormalities  (41).  These 
results suggest a specific importance of PTHrP signaling in 
endochondral  bone  formation.  Since  BMPs  modulate 
PTHrP responsiveness of chondrocytes (22), chondrogenic 
differentiation  must  be  coordinately  regulated  by  BMP- 
dependent signaling and PTHrP-dependent signaling. Fur- 
ther analysis  of PTHrP signaling in chondrogenesis  is in 
progress, using the DNA transfection technique that pro- 
duces perturbations in PTHrP signaling in ATDC5  ceils. 
Thus, ATDC5 cells provide a valuable opportunity for the 
molecular analysis of early chondrogenesis. 
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